Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001623632-26-000052
Filing Date
2026-01-08
Accepted
2026-01-08 11:56:04
Documents
5

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 12960
2 ovidexhibit1.htm EX-99 7934
3 ovidexhibit2.htm EX-99 14325
4 ovidexhibit3trd.htm EX-99 4184
5 ovidexhibit3acd.htm EX-99 4144
  Complete submission text file 0001623632-26-000052.txt   45561
Mailing Address 1001 LIBERTY AVENUE PITTSBURGH PA 15222
Business Address 1001 LIBERTY AVENUE PITTSBURGH PA 15222 4122881900
FEDERATED HERMES, INC. (Filed by) CIK: 0001056288 (see all company filings)

EIN.: 251111467 | State of Incorp.: PA | Fiscal Year End: 1231
Type: SCHEDULE 13G
SIC: 6282 Investment Advice
(CF Office: 02 Finance)

Mailing Address 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001
Business Address 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001 212-776-4381
Ovid Therapeutics Inc. (Subject) CIK: 0001636651 (see all company filings)

EIN.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-90350 | Film No.: 26518252
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)